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Halogenated salicylanilides and bithionol have
been reported to produce both allergic contact
sensitization and photoallergic contact sensitiza-
tion (1—4). The three principal clinically en-
countered "parent" compounds are 3,3',4',5
tetrachlorosalicylanilide (TCSA), 3,4', 5 tribromo-
salicylanilide (TBS) and bis (2 hydroxy-3 ,5
dichlorophenyl) sulfide (BITH), Bisphenol, Bithio-
nol) (Table I).
Irradiation of these halogenated salicylanilides
results in the formation of various derivatives (5,
6). In an attempt to understand the structural
features of the photosensitivity to 3,4', 5 tn-
bromosalicylanilide, patch tests and photopatch
tests with several of its derivatives and with cer-
tain other compounds were done in 3 patients who
clinically had developed photocontact dermatitis
due to one or more of the "parent" compounds.
Tests on unaffected skin with 2800 to 3200 A
radiation had shown a normal response in 2 of the
patients and a slightly decreased erythema thresh-
old in the third. No visible response was produced
with 3200 to 4500 A nonerythrogenic radiation.
Patch tests end photo patch tests—Three patch
tests with a 1% concentration in petrolatum of each
of the compounds listed in Table I were applied
to the lumbar area of the 3 test subjects. The
absence of primary irritancy of the test materials
had previously been established in suitable control
subjects. Forty-eight hours later, 2 of the 3 patch
tests with each compound were removed and
read. One of these sites was exposed to 2800 to
3200 A radiation (1 X 10° ergs/cm') and the other
to 3200 to 4500 A radiation (3 A 10 crgs/cm').
They were left "open" for 48 hours and then
(after a total of 96 hours) the reactions at these
irradiated sites were read and were compared
with the reaction at the third patch test site
which had been kept covered for the entire 96-hour
period.
RESULTS
Covered patch tests—No rediation.—T able I
indicates that no unequivocally positive reactions
to salicylanilides were seen. Questionable reac-
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tions were elicited in 2 of the 3 patients with
TCSA and in 1 of the 3 with BITH. No reactions
were produced by TBS.t No positive responses
were seen in covered patch tests to the brominated
salicylanilide derivatives, with the exception of one
patient who responded to 3,5 dibromosalicylic
acid.
Photopotch tests (2800 to 3200 A).—This radia-
tion produced no greater reaction at the patch
test sites than that observed in the surrounding
skin.
Photopetch tests (3200 to 4500 A).—Pronounced
papulo vesicular erythematous reactions were noted
at the TCSA test sites in all 3 patients, at the
BITH test sites in 2 of 3 patients and at the TBS
site in 2 of 3 patients.
The photopatch tests to lBS and its derivatives
4', 5 dibromosalicylanilide and 3,5 dibromosali-
cylanilide were markedly positive. Less pronounced
reactivity was noted to 2', 3,4', 5 tetrabromosali-
cylanilide. Of particular interest are the positive
photopatch tests to the salicylanilide cleavage
product, dibromosalicylic acid. It is noteworthy
also that no reaction was elicited with parabromo-
aniline and with 3,5 dibromophenol.
oIscvSSIoN
In vitro biochemical and biophysical studies (6)
strongly suggest that ultraviolet irradiation of
halogenated salicylanilides leads to formation of
free radicals. Following this event, halogen atoms
are displaced from the parent benzene ring (5, 6)
and new molecules are created. In vivo immuno-
logic studies concerning these halogenated sali-
cylanilides are complicated by the following
circumstances: (1) Allergic contact dermatitis
(without photosensitivity) occurs with chlorinated
(1, 2) and probably also brominated salicylanilide
derivatives, and these again may cross-react among
each other, as well as with bithionol and hexa-
ehlorophene (7, 8). (2) Allergic contact dermatitis(without photosensitivity) occurs also to hy-
drolytic products and to products resulting from
ultraviolet irradiation of these compounds, and
these reaction products also may cross-react among
each other. (3) Photoallergic contact dermatitis
t Pronounced positive responses were elicited in
covered patch tests with 3,3',4',5 TCSA follow-
ing repeated patch test and photopatch test ex-
posures to these compounds. These reactions will
be discussed in a subsequent publication.
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C = patch test (kept covered for 96 hours).P = photopatch test (kept. covered for 48 hours, then irradiated with 3200—4500 A and read 48 hours
'ater).
N.D. = not done
FIGURE 1








3,5 dibromosalicylanilide* (peptidase) 4',5 dibromosalicylanilide*
3,5 dibromosalicylic acid* parabromoaniline
U.





* = Photocontact sensitivity observed.
= Known pathway.
-s = Hypothetical pathway.
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occurs with both chlorinated (1—4) or brominatcd
(9—12) salicylanilides as well as with bisphenol
(Bithionol (11)). The derivatives of salicylanilides
may also be photosensitizers (12—14). (4) It is
difficult, or perhaps impossible, to obtain chemi-
cally pure salicylanilide compounds; and even
when these compounds are synthesized in pure
form, there is good reason to believe that ordinary
light exposure, normal ambient temperatures and
normal conditions prevailing in the skin, such as
hydrolytic peptidases, may readily convert them
into other derivatives. (5) Patch test exposures
per se may widen the pattern of cross-sensitivity
and induce primary sensitization (15). Figure 1
represents a schematic composite of reactions which
have been observed in different cases.
The new haptens created by ultraviolet radia-
tion and tested by us do not explain the mechanism
of photoallergie sensitivity to salieylanilides on
the basis of Burekhardt's theory (16): Neither
3 ,4',S tribromosalicylanilide nor UV 86OO.
dibromosalieylanilide (6) produced a reaction in
closed patch tests in our 3 patients. Thus, either the
"final" reaction product which is capable of elicit-
ing an allergic contact response—in the absence of
light—has not yet been identified or other factors
must be involved. Among these factors are further
biochemical alterations in the hapten following
removal of the initial bromine atom creating a
rather dissimilar compound or an increased tend-
ency to hapten protein bonding (complete antigen
formation (17)), the actual "photoantigen."
SUMMARy
1. Photosensitivity (3200 to 4500 A) to halo-
genated salieylanilide molecules was studied in
three patients by means of patch tests and photo-
patch tests.
2. The findings suggest that in photosensitivity
to these compounds: (a) the two benzene ring
moiety is not required; (b) the activity resides
in the salieylie acid ring; (e) an active carboxyl
group is necessary; (d) the number of halogens
on the ring is not crucial; (e) an aniline ring halo-
genated in the para position elicits no reaction.
3. Ultraviolet light probably initiates salieylan-
ilide photosensitivity by free radical formation
which can lead to a variety of biochemical altera-
tions, including changes in halogen content, direct
cleavage of the two rings, enzymatic hydrolysis,
facilitation of hapten-protein bonding (antigen
formation), etc.
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